Press Release Verastem Oncology Doses First Patient in TARGET-D 203 Phase 2 Registration-Directed Trial of VS-7375 Oral KRAS G12D (ON/OFF) Inhibitor for KRAS G12D-Mutated Metastatic Colorectal Cancer Jul 28
Press Release UWM Holdings Corporation to Announce Second Quarter 2026 Financial Results and Host Earnings Q&A Jul 28
Press Release Upstart Co-founder and CEO to Participate in Fireside Chat at the Bank of America 2026 SMID Cap Conference Jul 28
Press Release Huron Announces Record Second Quarter 2026 Financial Results and Increases 2026 Guidance Jul 28